2015年脑血管病临床进展

doi:10.3969/j.issn.1004-583X.2016.02.001

临床荟萃 ›› 2016, Vol. 31 ›› Issue (2): 117-122.doi: 10.3969/j.issn.1004-583X.2016.02.001

• 年度进展 • 下一篇

2015年脑血管病临床进展

张玉生,陈云玉,陈丹霞,董大伟,麦鸿成,徐安定

暨南大学附属第一医院神经内科和脑血管病中心,广东广州 510630

收稿日期:2016-01-20 出版日期:2016-02-05 发布日期:2016-04-18
通讯作者: 徐安定,Email: tlil@jnu.edu.cn
作者简介:徐安定,博士、教授、主任医师、博士生导师。暨南大学附属第一医院副院长,脑血管病中心主任,暨南大学临床神经科学研究所所长。担任中国卒中学会第一届理事会副会长、中国卒中中心联盟培训委员会副主任委员、中华预防医学会卒中预防与控制专业委员会副主任委员,卫生部脑卒中临床规范诊疗和医疗质量控制专家组专家、卫生部脑梗死单病种质量控制委员会委员、教育部临床医学教育指导委员会委员,中华医学会神经病学分会脑血管病学组委员,广东省医学会神经病学分会副主任委员,广东省医师学会神经病学分会副主任委员,广东省医学会神经病学分会脑血管病学组副组长,中美神经科促进会国际卒中学院讲师,《中国卒中杂志》和美国《Stroke》杂志中文版执行主编、《Stroke and Vascular Neurology》中国卒中学会与BMJ合办英文期刊副主编,《卒中大查房》副主编。国家基金委、国家教育部、广东省自然科学基金等评审专家。为中国脑血管病系列指南和共识作者之一,主持相关专家共识5部。主持国家“十二五”科技支撑计划项目、广东省自然科学基金、广州市科技计划重大专项等科研课题10余项,主持国内多中心研究2项。发表学术论文100余篇,其中SCI论文33篇。
基金资助:
国家自然科学基金资助项目(81171084);广东省自然科学基金资助项目(2014A030313384);广东省医学科研基金资助项目(A2014381);广州市科技计划资助项目(1561000289、155700029);暨南大学第一临床医学院科研培育专项基金资助项目(2014201)

Advances in clinical researches on cerebrovascular diseases in 2015

Zhang Yusheng, Chen Yunyu, Chen Danxia, Dong Dawei, Mai Hongcheng, Xu Anding

Department of Neurology and Stroke Center, the First Affiliated Hospital of Jinan University, Guangzhou 510630, China

Received:2016-01-20 Online:2016-02-05 Published:2016-04-18
Contact: Xu Anding, Email: tlil@jnu.edu.cn

摘要/Abstract

摘要： 2015年脑血管病临床研究取得重大进展。本文对急性缺血性卒中血管内治疗、脑动脉狭窄支架治疗、新型溶栓药物、神经保护剂、叶酸预防卒中、脑动脉夹层治疗、脑血管病指南、中国卒中建设发展等最新进展进行了总结和评价。

关键词: 卒中, 进展, 述评

Abstract: Many substantial advances have been made in the clinical researches on cerebrovascular diseases in 2015. The article reviews the following new advancements in endovascular treatment of acute ischemic stroke, stenting for symptomatic intracranial artery stenosis, new thrombolytic agents, neuroprotectants, folic acid therapy in primary prevention of stroke, treatment for cervical artery dissection, guidelines on cerebrovascular diseases, and development of the construction of stroke in China.

Key words: stroke, advances, review

中图分类号:

R743

张玉生,陈云玉,陈丹霞,董大伟,麦鸿成,徐安定. 2015年脑血管病临床进展[J]. 临床荟萃, 2016, 31(2): 117-122.

Zhang Yusheng, Chen Yunyu, Chen Danxia, Dong Dawei, Mai Hongcheng, Xu Anding. Advances in clinical researches on cerebrovascular diseases in 2015[J]. Clinical Focus, 2016, 31(2): 117-122.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://huicui.hebmu.edu.cn/CN/10.3969/j.issn.1004-583X.2016.02.001

https://huicui.hebmu.edu.cn/CN/Y2016/V31/I2/117

参考文献

[1] Kidwell CS, Jahan R, Gornbein J, et al. A trial of imaging selection and endovascular treatment for ischemic stroke[J]. N Engl J Med, 2013, 368(10): 914-923.
[2] Ciccone A, Valvassori L, Nichelatti M, et al. Endovascular treatment for acute ischemic stroke[J]. N Engl J Med, 2013, 368(10):904-913.
[3] Broderick JP, Palesch YY, Demchuk AM, et al. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke[J]. N Engl J Med, 2013, 368(10):893-903.
[4] Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke[J]. N Engl J Med, 2015, 372(1):11-20.
[5] Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection[J]. N Engl J Med, 2015, 372(11):1009-1018.
[6] Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke[J]. N Engl J Med, 2015, 372 (11): 1019-1030.
[7] Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke[J]. N Engl J Med, 2015, 372(24): 2285-2295.
[8] Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke[J]. N Engl J Med, 2015, 372(24):2296-2306.
[9] 中国卒中学会, 中国卒中学会神经介入分会, 中华预防医学会卒中预防与控制专业委员会介入学组. 急性缺血性卒中血管内治疗中国指南2015[J]. 中国卒中杂志, 2015, 10(7):590-606.
[10] Powers WJ, Derdeyn CP, Biller J, et al. 2015 American Heart Association/ American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46(10):3020-3035.
[11] Zaidat OO, Fitzsimmons BF, Woodward BK, et al. Effect of a balloon- expandable intracranial stent vs medical therapy on risk of stroke in patients with symptomatic intracranial stenosis: the VISSIT randomized clinical trial[J]. JAMA, 2015, 313(12):1240-1248.
[12] Compter A, van der Worp HB, Schonewille WJ, et al. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial[J]. Lancet Neurol, 2015, 14(6):606-614.
[13] Miao Z, Zhang Y, Shuai J, et al. Thirty-day outcome of a multicenter registry study of stenting for symptomatic intracranial artery stenosis in China[J]. Stroke, 2015,46(10):2822-2829.
[14] Huang X, Cheripelli BK, Lloyd SM, et al. Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study[J]. Lancet Neurol, 2015, 14(4):368-376.
[15] Coutts SB, Dubuc V, Mandzia J, et al. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion[J]. Stroke, 2015, 46(3):769-774.
[16] Albers GW, von Kummer R, Truelsen T, et al. Safety and efficacy of desmoteplase given 3-9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trial[J]. Lancet Neurol, 2015, 14(6): 575-584.
[17] Saver JL, Starkman S, Eckstein M, et al. Prehospital use of magnesium sulfate as neuroprotection in acute stroke[J]. N Engl J Med, 2015, 372(6):528-536.
[18] 胡大一, 徐希平. 有效控制“H型”高血压预防卒中的新思路[J]. 中华内科杂志, 2008, 47(12):976-977.
[19] Huo Y, Li J, Qin X, et al. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial[J]. JAMA, 2015, 313(13):1325-1335.
[20] CADISS trial investigators, Markus HS, Hayter E, et al. Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial[J]. Lancet Neurol, 2015, 14(4):361-367.
[21] Hemphill JC 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2015, 46(7):2032-2060.
[22] Torbey MT, B sel J, Rhoney DH, et al. Evidence-based guidelines for the management of large hemispheric infarction: a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine[J]. Neurocrit Care, 2015, 22(1):146-164.
[23] Smith CJ, Kishore AK, Vail A, et al. Diagnosis of stroke-associated pneumonia: recommendations from the pneumonia in stroke consensus group[J]. Stroke, 2015, 46(8):2335-2340.
[24] Harris D, Hall C, Lobay K, et al. Canadian Association of Emergency Physicians position statement on acute ischemic stroke[J]. CJEM, 2015, 17(2):217-226.
[25] Eskes GA, Lanct t KL, Herrmann N, et al. Canadian stroke best practice recommendations: mood, aognition and fatigue following stroke practice guidelines, update 2015[J]. Int J Stroke, 2015, 10(7):1130-1140.
[26] Jung KH, Yu KH, Kim YD, et al. Antithrombotic management of patients with nonvalvular atrial fibrillation and ischemic stroke or transient ischemic attack: executive summary of the Korean clinical practice guidelines for stroke[J]. J Stroke, 2015, 17(2):210-215.
[27] Middleton S, Grimley R, Alexandrov AW. Triage, treatment, and transfer: evidence-based clinical practice recommendations and models of nursing care for the first 72 hours of admission to hospital for acute stroke[J]. Stroke, 2015, 46(2):e18-25.
[28] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志, 2015, 48(4):246-257.
[29] 中华医学会神经病学分会, 中华医学会神经病学分会脑血管病学组. 中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2014[J]. 中华神经科杂志, 2015, 48(4):258-273.
[30] 中华医学会神经病学分会, 中华医学会神经病学分会神经血管介入协作组,急性缺血性脑卒中介入诊疗指南撰写组. 中国急性缺血性脑卒中早期血管内介入诊疗指南[J]. 中华神经科杂志, 2015, 48(5):356-361.
[31] 国家卫生和计划生育委员会, 神经内科医疗质量控制中心. 中国卒中中心建设指南[J]. 中国卒中杂志, 2015, 10(6):499-507.
[32] 中华预防医学会卒中预防与控制专业委员会介入学组. 缺血性脑血管病介入治疗抗血小板策略中国专家共识[J]. 中华医学杂志, 2015, 95(11):803-809.
[33] 中华预防医学会卒中预防与控制专业委员会脑血管病介入学组. 症状性动脉粥样硬化性椎动脉起始部狭窄血管内治疗中国专家共识[J]. 中华医学杂志, 2015, 95(9):648-653.

2015年脑血管病临床进展

Advances in clinical researches on cerebrovascular diseases in 2015

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	王红, 金润浩. 社区老年人自我忽视的研究进展[J]. 临床荟萃, 2024, 39(2): 164-167.
[2]	李雯琳, 张志. 心房颤动患者左心耳形态结构和功能与左心耳血栓及心源性卒中的关系研究进展[J]. 临床荟萃, 2024, 39(2): 168-171.
[3]	张学谦, 李阳, 徐国栋, 吕佩源. 卵圆孔未闭所致急性脑梗死患者人口学特征、临床及影像学等特征分析[J]. 临床荟萃, 2023, 38(6): 500-503.
[4]	辛燕红, 郎桂艳, 陈子为, 王东玉. 中性粒细胞-淋巴细胞比值和血小板-淋巴细胞比值预测急性轻型缺血性脑卒中患者认知障碍的价值[J]. 临床荟萃, 2023, 38(6): 504-509.
[5]	陆知非, 王高卿, 高过. 肝门部胆管癌的非手术治疗进展[J]. 临床荟萃, 2023, 38(5): 473-476.
[6]	王凤华, 魏茂提. 干式桑拿疗法治疗慢性心力衰竭的研究进展[J]. 临床荟萃, 2023, 38(4): 369-372.
[7]	贺翔渝, 潘燕, 张小林. 血清脂蛋白相关磷脂酶A2水平与急性缺血性脑卒中病情及预后的关系[J]. 临床荟萃, 2023, 38(4): 315-318.
[8]	赵越, 张少华, 赵振彪, 闫彦宁, 孙增鑫, 王晓晗, 吕佩源, 尹昱. 右侧忽略患者眼动追踪技术评估及认知训练1例并文献复习[J]. 临床荟萃, 2023, 38(3): 268-272.
[9]	姚美芬, 丁刚玉, 徐建华, 王国江. 重组组织型纤溶酶原激活剂治疗急性轻型缺血性脑卒中的有效性和安全性[J]. 临床荟萃, 2023, 38(3): 227-231.
[10]	贾阳娟, 韩凝, 郭慧, 李岩鹏, 李灿灿, 李建国. MMSE和MoCA对卒中后轻度血管性认知障碍早期筛查的价值[J]. 临床荟萃, 2023, 38(3): 221-226.
[11]	马宏莉, 陆皓, 王丹, 焦海星, 李一珂, 李思雨, 吕静. 脑卒中患者残疾危险因素的meta分析[J]. 临床荟萃, 2023, 38(2): 111-116.
[12]	张芳, 张伊超, 贾辛未, 李建龙, 陈春红. 心房颤动高CHA2DS2-VASc评分≥75岁住院患者随访1年结果分析[J]. 临床荟萃, 2023, 38(2): 117-120.
[13]	贾阳娟, 韩凝, 郭慧, 李灿灿, 李建国. 不同画钟试验识别急性期卒中后非痴呆型认知障碍的价值[J]. 临床荟萃, 2023, 38(2): 143-148.
[14]	翟华珍, 李凌翔, 林秋满, 赖颖瑜, 杨心怡, 邓敏. 重症急性胰腺炎治疗及营养支持的研究进展[J]. 临床荟萃, 2023, 38(12): 1135-1139.
[15]	廖坤锋, 姚依松, 杨金盘, 杨西宁, 李亚如, 周红颜, 梁飘. 2型糖尿病患者恐惧疾病进展的现状及影响因素[J]. 临床荟萃, 2023, 38(12): 1095-1100.